 Vijaya Vemulakonda
Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urologic Surgical Procedures | 17 | 2025 | 118 | 3.910 |
Why?
| | Ureteral Obstruction | 7 | 2024 | 63 | 3.880 |
Why?
| | Hydronephrosis | 7 | 2024 | 36 | 2.680 |
Why?
| | Urology | 8 | 2024 | 63 | 2.220 |
Why?
| | Kidney Pelvis | 4 | 2024 | 22 | 1.740 |
Why?
| | Vesico-Ureteral Reflux | 6 | 2025 | 38 | 1.640 |
Why?
| | Urinary Bladder | 6 | 2022 | 195 | 1.520 |
Why?
| | Renal Insufficiency | 3 | 2025 | 172 | 1.490 |
Why?
| | Electronic Health Records | 6 | 2022 | 1196 | 1.430 |
Why?
| | Fetal Diseases | 2 | 2022 | 194 | 1.280 |
Why?
| | Kidney | 7 | 2025 | 1497 | 1.230 |
Why?
| | Urinary Tract Infections | 6 | 2025 | 210 | 1.210 |
Why?
| | Urogenital Abnormalities | 5 | 2025 | 71 | 1.170 |
Why?
| | Infant | 28 | 2025 | 10077 | 1.070 |
Why?
| | Pediatrics | 4 | 2019 | 1121 | 0.930 |
Why?
| | Urethral Diseases | 3 | 2022 | 16 | 0.920 |
Why?
| | Urinary Tract | 2 | 2024 | 47 | 0.910 |
Why?
| | Urinary Bladder, Neurogenic | 6 | 2025 | 46 | 0.850 |
Why?
| | Decision Making | 3 | 2024 | 977 | 0.820 |
Why?
| | Child | 40 | 2026 | 22707 | 0.810 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1371 | 0.790 |
Why?
| | Ultrasonography, Doppler | 1 | 2024 | 126 | 0.790 |
Why?
| | Kidney Transplantation | 3 | 2026 | 712 | 0.780 |
Why?
| | Urologists | 2 | 2020 | 17 | 0.740 |
Why?
| | Urethral Obstruction | 1 | 2022 | 7 | 0.740 |
Why?
| | Amniotic Fluid | 1 | 2022 | 79 | 0.710 |
Why?
| | Urologic Diseases | 3 | 2018 | 42 | 0.670 |
Why?
| | Multicystic Dysplastic Kidney | 1 | 2020 | 3 | 0.660 |
Why?
| | Child, Preschool | 25 | 2026 | 11853 | 0.660 |
Why?
| | Kidney Diseases, Cystic | 1 | 2020 | 24 | 0.650 |
Why?
| | Hypospadias | 2 | 2018 | 31 | 0.640 |
Why?
| | Ultrasonography, Prenatal | 5 | 2022 | 295 | 0.630 |
Why?
| | Documentation | 1 | 2022 | 199 | 0.620 |
Why?
| | Biomedical Research | 2 | 2018 | 717 | 0.600 |
Why?
| | Humans | 64 | 2026 | 145474 | 0.590 |
Why?
| | Fasting | 1 | 2020 | 279 | 0.560 |
Why?
| | Stakeholder Participation | 1 | 2019 | 84 | 0.550 |
Why?
| | Neurotoxicity Syndromes | 1 | 2018 | 40 | 0.550 |
Why?
| | Urinary Incontinence | 2 | 2016 | 65 | 0.540 |
Why?
| | Qualitative Research | 5 | 2022 | 1674 | 0.540 |
Why?
| | Postnatal Care | 2 | 2015 | 76 | 0.530 |
Why?
| | Parents | 3 | 2023 | 1403 | 0.530 |
Why?
| | Urinary Fistula | 1 | 2017 | 9 | 0.520 |
Why?
| | Preoperative Care | 1 | 2020 | 380 | 0.520 |
Why?
| | Retrospective Studies | 26 | 2026 | 17291 | 0.510 |
Why?
| | Prenatal Diagnosis | 2 | 2020 | 196 | 0.500 |
Why?
| | Epispadias | 1 | 2016 | 4 | 0.490 |
Why?
| | Bladder Exstrophy | 1 | 2016 | 18 | 0.490 |
Why?
| | Urogenital Surgical Procedures | 1 | 2016 | 5 | 0.490 |
Why?
| | Outpatients | 1 | 2020 | 447 | 0.480 |
Why?
| | Female | 41 | 2026 | 78844 | 0.480 |
Why?
| | Urogenital System | 1 | 2016 | 16 | 0.480 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2016 | 4 | 0.480 |
Why?
| | Infant, Newborn | 12 | 2025 | 6447 | 0.460 |
Why?
| | Kidney Failure, Chronic | 1 | 2022 | 599 | 0.460 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 363 | 0.460 |
Why?
| | Spinal Dysraphism | 2 | 2017 | 110 | 0.440 |
Why?
| | Appointments and Schedules | 2 | 2014 | 96 | 0.440 |
Why?
| | Risk Assessment | 5 | 2024 | 3747 | 0.440 |
Why?
| | Anesthesia | 1 | 2018 | 256 | 0.430 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2008 | 258 | 0.430 |
Why?
| | Cultural Diversity | 2 | 2022 | 83 | 0.420 |
Why?
| | Anus, Imperforate | 1 | 2014 | 24 | 0.400 |
Why?
| | Hernia, Umbilical | 1 | 2014 | 21 | 0.400 |
Why?
| | Urethra | 1 | 2014 | 56 | 0.390 |
Why?
| | Male | 37 | 2026 | 72842 | 0.390 |
Why?
| | Internship and Residency | 4 | 2024 | 1267 | 0.370 |
Why?
| | Wilms Tumor | 1 | 2013 | 89 | 0.360 |
Why?
| | Tumor Burden | 1 | 2013 | 325 | 0.360 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2012 | 79 | 0.350 |
Why?
| | Data Collection | 1 | 2014 | 640 | 0.340 |
Why?
| | Physicians | 1 | 2020 | 955 | 0.340 |
Why?
| | Patient Selection | 1 | 2015 | 738 | 0.340 |
Why?
| | Botulinum Toxins, Type A | 3 | 2011 | 59 | 0.330 |
Why?
| | Adolescent | 19 | 2026 | 22529 | 0.330 |
Why?
| | Scoliosis | 1 | 2014 | 221 | 0.330 |
Why?
| | Referral and Consultation | 1 | 2017 | 867 | 0.330 |
Why?
| | Ultrasonography | 4 | 2025 | 785 | 0.330 |
Why?
| | Pregnancy | 5 | 2024 | 7202 | 0.300 |
Why?
| | Dextrans | 1 | 2009 | 84 | 0.290 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1747 | 0.280 |
Why?
| | Prospective Studies | 6 | 2025 | 8057 | 0.280 |
Why?
| | Tertiary Care Centers | 3 | 2019 | 195 | 0.280 |
Why?
| | Cystitis | 2 | 2005 | 24 | 0.280 |
Why?
| | Prune Belly Syndrome | 1 | 2007 | 8 | 0.270 |
Why?
| | Postoperative Complications | 5 | 2024 | 2970 | 0.260 |
Why?
| | Ethics, Professional | 1 | 2007 | 14 | 0.260 |
Why?
| | Hyaluronic Acid | 1 | 2009 | 226 | 0.250 |
Why?
| | Diurnal Enuresis | 1 | 2006 | 1 | 0.250 |
Why?
| | Patient Compliance | 2 | 2026 | 587 | 0.250 |
Why?
| | Follow-Up Studies | 6 | 2019 | 5423 | 0.250 |
Why?
| | Professional Competence | 1 | 2007 | 91 | 0.240 |
Why?
| | Competency-Based Education | 1 | 2007 | 81 | 0.240 |
Why?
| | Stomach Neoplasms | 1 | 2008 | 128 | 0.240 |
Why?
| | Education, Medical, Graduate | 2 | 2024 | 562 | 0.230 |
Why?
| | Adenoma | 1 | 2007 | 218 | 0.220 |
Why?
| | Mullerian Ducts | 1 | 2025 | 17 | 0.220 |
Why?
| | Congenital Abnormalities | 2 | 2025 | 109 | 0.220 |
Why?
| | Biocompatible Materials | 1 | 2009 | 429 | 0.220 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2025 | 29 | 0.220 |
Why?
| | Incidence | 4 | 2024 | 2923 | 0.220 |
Why?
| | Databases, Factual | 3 | 2022 | 1490 | 0.220 |
Why?
| | Neuromuscular Agents | 1 | 2005 | 46 | 0.210 |
Why?
| | Feasibility Studies | 2 | 2022 | 1111 | 0.200 |
Why?
| | Renal Artery | 1 | 2024 | 43 | 0.200 |
Why?
| | Dissent and Disputes | 1 | 2023 | 18 | 0.200 |
Why?
| | Abnormalities, Multiple | 1 | 2025 | 199 | 0.200 |
Why?
| | Muscle, Smooth | 2 | 2022 | 153 | 0.190 |
Why?
| | Vascular Resistance | 1 | 2024 | 370 | 0.190 |
Why?
| | Urinary Bladder Diseases | 1 | 2022 | 18 | 0.190 |
Why?
| | Drug Prescriptions | 1 | 2024 | 288 | 0.180 |
Why?
| | Duodenum | 1 | 2022 | 77 | 0.180 |
Why?
| | Patient Care | 1 | 2023 | 119 | 0.180 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3413 | 0.180 |
Why?
| | Sexual Development | 1 | 2022 | 17 | 0.180 |
Why?
| | Propensity Score | 1 | 2024 | 377 | 0.180 |
Why?
| | Laparoscopy | 2 | 2022 | 481 | 0.180 |
Why?
| | United States | 9 | 2025 | 16098 | 0.180 |
Why?
| | Ureter | 1 | 2022 | 36 | 0.180 |
Why?
| | Postoperative Period | 2 | 2020 | 351 | 0.180 |
Why?
| | Probability | 1 | 2022 | 307 | 0.180 |
Why?
| | Social Justice | 1 | 2022 | 81 | 0.170 |
Why?
| | Anti-Bacterial Agents | 4 | 2025 | 1923 | 0.170 |
Why?
| | Urination | 3 | 2014 | 47 | 0.170 |
Why?
| | Surgical Wound Infection | 1 | 2025 | 329 | 0.170 |
Why?
| | Bacteremia | 1 | 2024 | 222 | 0.170 |
Why?
| | Injury Severity Score | 1 | 2023 | 599 | 0.170 |
Why?
| | Urography | 2 | 2014 | 19 | 0.170 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 345 | 0.170 |
Why?
| | Renal Replacement Therapy | 1 | 2022 | 100 | 0.170 |
Why?
| | Hospitals, Pediatric | 2 | 2025 | 558 | 0.170 |
Why?
| | Registries | 2 | 2022 | 2406 | 0.160 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 1149 | 0.160 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2025 | 390 | 0.160 |
Why?
| | Trauma Centers | 1 | 2023 | 466 | 0.160 |
Why?
| | Adenocarcinoma | 1 | 2008 | 925 | 0.160 |
Why?
| | Actins | 1 | 2022 | 425 | 0.160 |
Why?
| | Wounds, Nonpenetrating | 1 | 2023 | 321 | 0.160 |
Why?
| | Ambulatory Care Facilities | 1 | 2022 | 269 | 0.160 |
Why?
| | Treatment Outcome | 6 | 2025 | 11772 | 0.150 |
Why?
| | Clinical Competence | 1 | 2008 | 1243 | 0.150 |
Why?
| | Cohort Studies | 4 | 2024 | 6013 | 0.150 |
Why?
| | Patient Portals | 1 | 2019 | 51 | 0.140 |
Why?
| | General Surgery | 2 | 2024 | 206 | 0.140 |
Why?
| | User-Computer Interface | 1 | 2019 | 165 | 0.140 |
Why?
| | Bacteriuria | 1 | 2018 | 12 | 0.140 |
Why?
| | Kidney Diseases | 1 | 2022 | 425 | 0.140 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2018 | 35 | 0.140 |
Why?
| | Ambulatory Care | 2 | 2022 | 609 | 0.140 |
Why?
| | Disorders of Sex Development | 1 | 2018 | 40 | 0.130 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2024 | 668 | 0.130 |
Why?
| | Renal Dialysis | 1 | 2022 | 466 | 0.130 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 6066 | 0.130 |
Why?
| | Social Support | 1 | 2022 | 646 | 0.130 |
Why?
| | Cystostomy | 1 | 2017 | 11 | 0.130 |
Why?
| | Curriculum | 1 | 2024 | 1070 | 0.130 |
Why?
| | Risk Factors | 6 | 2026 | 10885 | 0.120 |
Why?
| | Adult | 9 | 2025 | 40777 | 0.120 |
Why?
| | Genital Diseases, Male | 1 | 2016 | 16 | 0.120 |
Why?
| | Mass Screening | 1 | 2025 | 1360 | 0.120 |
Why?
| | Analgesia | 1 | 2017 | 106 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 875 | 0.120 |
Why?
| | Fetus | 1 | 2020 | 804 | 0.120 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1149 | 0.120 |
Why?
| | Perioperative Care | 1 | 2018 | 231 | 0.110 |
Why?
| | Global Health | 1 | 2018 | 403 | 0.110 |
Why?
| | Reoperation | 1 | 2018 | 633 | 0.110 |
Why?
| | Length of Stay | 3 | 2025 | 1349 | 0.100 |
Why?
| | Health Information Exchange | 1 | 2014 | 23 | 0.100 |
Why?
| | Recovery of Function | 1 | 2018 | 716 | 0.100 |
Why?
| | Age Factors | 3 | 2018 | 3342 | 0.100 |
Why?
| | Cloaca | 1 | 2014 | 52 | 0.100 |
Why?
| | ROC Curve | 1 | 2015 | 617 | 0.100 |
Why?
| | Program Evaluation | 2 | 2008 | 943 | 0.100 |
Why?
| | Caregivers | 1 | 2022 | 1073 | 0.100 |
Why?
| | Cystoscopy | 2 | 2011 | 21 | 0.090 |
Why?
| | Urinary Retention | 1 | 2011 | 24 | 0.080 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 337 | 0.080 |
Why?
| | Sex Factors | 3 | 2018 | 2105 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2930 | 0.080 |
Why?
| | Ureteroscopy | 1 | 2009 | 15 | 0.070 |
Why?
| | Injections | 1 | 2009 | 199 | 0.070 |
Why?
| | Electrocoagulation | 1 | 2007 | 35 | 0.070 |
Why?
| | Stomach | 1 | 2008 | 111 | 0.070 |
Why?
| | Logistic Models | 2 | 2026 | 2134 | 0.060 |
Why?
| | Anastomosis, Surgical | 1 | 2008 | 162 | 0.060 |
Why?
| | Medical Staff, Hospital | 1 | 2007 | 80 | 0.060 |
Why?
| | Young Adult | 4 | 2025 | 14218 | 0.060 |
Why?
| | Professional Role | 1 | 2007 | 169 | 0.060 |
Why?
| | Urothelium | 1 | 2005 | 33 | 0.060 |
Why?
| | Urinalysis | 1 | 2025 | 83 | 0.060 |
Why?
| | Administration, Intravesical | 1 | 2005 | 17 | 0.060 |
Why?
| | Educational Measurement | 1 | 2008 | 326 | 0.050 |
Why?
| | Program Development | 1 | 2007 | 368 | 0.050 |
Why?
| | Biopsy | 1 | 2007 | 1082 | 0.050 |
Why?
| | Colorado | 1 | 2014 | 4553 | 0.050 |
Why?
| | Faculty, Medical | 1 | 2007 | 303 | 0.050 |
Why?
| | Phimosis | 1 | 2003 | 1 | 0.050 |
Why?
| | Circumcision, Male | 1 | 2003 | 16 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2769 | 0.050 |
Why?
| | Treatment Failure | 1 | 2024 | 360 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4295 | 0.050 |
Why?
| | Adenosine Triphosphate | 1 | 2005 | 500 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2005 | 2524 | 0.050 |
Why?
| | Disease Management | 1 | 2006 | 653 | 0.050 |
Why?
| | Career Choice | 1 | 2024 | 234 | 0.040 |
Why?
| | Chronic Disease | 2 | 2005 | 1808 | 0.040 |
Why?
| | Abortion, Induced | 1 | 2024 | 110 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3904 | 0.040 |
Why?
| | Advisory Committees | 1 | 2022 | 229 | 0.040 |
Why?
| | Rats | 2 | 2005 | 5584 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1891 | 0.040 |
Why?
| | Cryptorchidism | 1 | 2018 | 16 | 0.030 |
Why?
| | Urolithiasis | 1 | 2018 | 11 | 0.030 |
Why?
| | Intraoperative Period | 1 | 2018 | 69 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 89 | 0.030 |
Why?
| | Urine | 1 | 2018 | 64 | 0.030 |
Why?
| | Stents | 1 | 2022 | 564 | 0.030 |
Why?
| | Constipation | 1 | 2018 | 98 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1547 | 0.030 |
Why?
| | Hospitalization | 1 | 2025 | 2460 | 0.030 |
Why?
| | Information Storage and Retrieval | 1 | 2014 | 123 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2381 | 0.020 |
Why?
| | Quality Improvement | 1 | 2020 | 1295 | 0.020 |
Why?
| | Injections, Intralesional | 1 | 2011 | 35 | 0.020 |
Why?
| | Urodynamics | 1 | 2011 | 44 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3623 | 0.020 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2011 | 62 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3204 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4316 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 1044 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2011 | 296 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1266 | 0.020 |
Why?
| | Physical Therapy Modalities | 1 | 2011 | 336 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 7123 | 0.010 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2005 | 8 | 0.010 |
Why?
| | Mechanoreceptors | 1 | 2005 | 15 | 0.010 |
Why?
| | Animals | 2 | 2005 | 38030 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2005 | 41 | 0.010 |
Why?
| | Physical Stimulation | 1 | 2005 | 68 | 0.010 |
Why?
| | Cyclophosphamide | 1 | 2005 | 270 | 0.010 |
Why?
| | Sensory Receptor Cells | 1 | 2005 | 98 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2005 | 429 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2005 | 4560 | 0.010 |
Why?
|
|
Vemulakonda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|